Abstract
Within past 30 years of progress since its first clinical use, gene therapy (GT) has gone from an experimental field to the most actively developing area of modern biomedicine. Significant advances during this period were mixed with sharp declines, and this pathway taken together with new ideas and concepts has formed the main milestones which this short review addresses. Analysis of accumulated experience provides directions, makes up for emerging prospects for the development of GT and sets the vector for their implementation. At the same time, we should not forget about the crucial issues of ethics and safety, which are the cornerstones supporting the use of GT in human. This report briefly summarizes the most important events and fundamental provisions that have shaped the modern landscape of GT, outlines its prospects and problematic issues in the field.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
